Alan Siroy

Alan Siroy, MD, MPH, FCAP

Assistant Professor (Courtesy Teaching Faculty)

Department: MD-PATHOLOGY-GENERAL
Business Phone: (352) 376-1611
Business Email: asiroy@ufl.edu

Teaching Profile

Courses Taught
2018
DEN6350 General Pathology

Board Certifications

  • Anatomic Pathology
    American Board of Pathology
  • Dermatopathology
    American Board of Pathology & American Board of Dermatology

Publications

Academic Articles
2020
Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions.
Journal of investigative medicine high impact case reports. 8 [DOI] 10.1177/2324709620940496. [PMID] 32643953.
2020
Clinical and histopathologic features differentiating acute generalized exanthematous pustulosis and pustular psoriasis: A retrospective series.
Journal of the American Academy of Dermatology. 83(1):265-267 [DOI] 10.1016/j.jaad.2020.03.015. [PMID] 32173359.
2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy.
Cancers. 11(6) [DOI] 10.3390/cancers11060754. [PMID] 31146499.
2019
Intravascular nevus cell aggregate in axillary lymph node mimicking metastatic breast carcinoma.
The breast journal. 25(4):726-727 [DOI] 10.1111/tbj.13310. [PMID] 31087469.
2019
Novel diagnostic imaging features of facial lupus panniculitis: ultrasound, CT, and MR imaging with histopathology correlate.
Clinical imaging. 58:177-181 [DOI] 10.1016/j.clinimag.2019.07.006. [PMID] 31386960.
2019
Reactive Perforating Collagenosis in End-Stage Renal Disease: Not All that Itches Is Uremic Pruritis!
The American journal of medicine. 132(8):e658-e660 [DOI] 10.1016/j.amjmed.2019.03.015. [PMID] 30953631.
2019
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.
The Journal of investigative dermatology. 139(3):728-731 [DOI] 10.1016/j.jid.2018.10.009. [PMID] 30798855.
2017
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
Human pathology. 59:48-54 [DOI] 10.1016/j.humpath.2016.09.010. [PMID] 27666765.
2017
Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
Cancer. 123(8):1372-1381 [DOI] 10.1002/cncr.30463. [PMID] 27911979.
2017
Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.
Journal of drugs in dermatology : JDD. 16(10):1050-1052 [PMID] 29036262.
2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
BMC medicine. 14(1) [PMID] 27776519.
2016
Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Scientific reports. 6 [DOI] 10.1038/srep19649. [PMID] 26787600.
2016
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma.
Archives of pathology & laboratory medicine. 140(4):355-7 [DOI] 10.5858/arpa.2015-0278-CP. [PMID] 26340412.
2015
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
The Journal of investigative dermatology. 135(2):508-515 [DOI] 10.1038/jid.2014.366. [PMID] 25148578.
2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
Journal of cutaneous pathology. 42(5):308-17 [DOI] 10.1111/cup.12481. [PMID] 25754356.
2014
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research. 20(21):5527-36 [DOI] 10.1158/1078-0432.CCR-14-1027. [PMID] 25165098.
2013
A novel approach: chest wall cyst excised by MIS.
Journal of surgical case reports. 2013(9) [DOI] 10.1093/jscr/rjt085. [PMID] 24963907.
2013
MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer.
Human pathology. 44(10):2159-66 [DOI] 10.1016/j.humpath.2013.04.010. [PMID] 23845471.
2012
Metastatic Crohn disease: a rare cutaneous entity.
Archives of pathology & laboratory medicine. 136(3):329-32 [DOI] 10.5858/arpa.2010-0666-RS. [PMID] 22372910.
2011
Primary melanoma of the bladder.
The Journal of urology. 185(3):1096-7 [DOI] 10.1016/j.juro.2010.12.004. [PMID] 21256523.
2007
Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
Journal of the American Academy of Dermatology. 56(3):500-5 [PMID] 17166623.

Education

Multidisciplinary Pathology Fellowship – Molecular Melanoma Diagnostics, Dermatopathology, and Molecular Genetic Pathology)
2013-2017 · The University of Texas – M.D. Anderson Cancer Center – Houston, TX
Surgical Pathology Fellowship
2012-2013 · Mayo Clinic – Rochester, MN
Anatomic and Clinical Pathology Residency
2008-2012 · University Hospitals Cleveland Medical Center – Case Western Reserve University School of Medicine – Cleveland, OH
Intern Year – Anesthesiology & Surgical Critical Care
2007-2008 · Barnes-Jewish Hospital – Washington University School of Medicine – St. Louis, MO
Doctor of Medicine (MD)
2003-2007 · Southern Illinois University School of Medicine – Springfield, IL
Master of Public Health (MPH – Biomedical Ethics and Health Law)
2000-2003 · Boston University School of Public Health – Boston, MA
Bachelor of Science (BS – Biology, Theology)
1996-2000 · Boston College – Chestnut Hill, MA

Contact Details

Phones:
Business:
(352) 376-1611
Emails:
Business:
asiroy@ufl.edu
Addresses:
Business Street:
1601 SW ARCHER RD
GAINESVILLE FL 32608